---

---

symbols : NVS   

save search

---

Global Drug Delivery Systems (DDS) Markets 2021-2027 - Increasing R&D Expenditures of Innovator Companies and the Trend of Patent Portfolio Expansion
Published: 2021-07-29 (Crawled : 15:15) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M |

Health Technology

| 9.3% | O: 0.62% H: 0.73% C: 0.42%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 7.03% | O: 0.74% H: 0.22% C: -0.41%
CTLT | $55.95 -0.14% 0.0% 2M |

Health Technology

| -51.98% | O: 0.23% H: 2.96% C: 2.18%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 41.54% | O: 0.4% H: 0.08% C: -0.13%
TFFP | $3.04 2.36% 2.3% 13K |

Health Technology

| -65.2% | O: 2.89% H: 0.0% C: -1.57%
LGND | $70.87 1.4% 1.38% 150K |

Health Technology

| -42.49% | O: -0.09% H: 1.78% C: -3.55%
HALO 4 | $39.095 0.32% 0.32% 620K |

Health Technology

| -5.98% | O: 0.34% H: 1.37% C: -1.63%
ARCT 4 | $27.0 -3.33% -3.44% 270K |

Health Technology

| -18.39% | O: -0.06% H: 1.09% C: -6.17%
AQST | $3.905 -8.76% -9.6% 2.1M |

Health Technology

| 11.11% | O: 0.57% H: 1.7% C: -2.27%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 11.77% | O: 0.09% H: 0.29% C: -0.82%
expansion drug patent drug delivery liver

---

The Worldwide Inhalable Drugs Industry is Expected to Reach $49.47 Billion by 2027: Players Include AptarGroup, AstraZeneca, Cipla, GEA and GSK
Published: 2023-02-28 (Crawled : 04:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 33.95% | O: -2.64% H: 0.0% C: -0.1%
PFE | News 4 | $26.27 -0.19% -0.15% 23M |

Health Technology

| -35.58% | O: -0.69% H: 0.52% C: 0.17%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 14.96% | O: -0.48% H: 0.05% C: -1.2%
ATR | $140.01 0.19% 0.0% 430K |

Process Industries

| 19.98% | O: -0.03% H: 1.25% C: 0.06%
TFFP | $3.04 2.36% 2.3% 13K |

Health Technology

| 301.39% | O: 0.01% H: 12.67% C: 6.65%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -1.09% | O: -1.4% H: 0.0% C: 0.0%
expected

---

Global Tacrolimus Market to Surpass US$ 9,380.2 Million by 2030 - Coherent Market Insights
Published: 2022-06-17 (Crawled : 19:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| Email alert Add to watchlist
ALPMF | News | $9.5 43.47% 1.2K |

Health Technology

| Email alert Add to watchlist
TFFP | $3.04 2.36% 2.3% 13K |

Health Technology

| Email alert Add to watchlist
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| Email alert Add to watchlist
tacrolimus market

---

Atopic Dermatitis Drugs Market to grow by USD 4.7 billion from 2022-2027 | North America to account for 36% of market growth- Technavio
Published: 2023-10-17 (Crawled : 05:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -25.67% | O: -0.27% H: 1.38% C: 0.83%
VTRS | News A | $11.55 1.67% 1.65% 7.2M |

Health Technology

| 21.96% | O: -0.95% H: 1.81% C: 0.53%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.56% | O: 0.2% H: 0.44% C: -0.56%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 13.44% | O: -0.32% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -13.15% | O: -0.4% H: 0.0% C: 0.0%
PHGE | $0.3274 -5.51% 3.82% 130K |

Health Technology

| 13.33% | O: 5.0% H: 3.17% C: -1.56%
america dermatitis market

---

Global Gene Therapy Market to Grow by $4.61 Billion During 2023-2027
Published: 2023-03-14 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 40.92% | O: -0.18% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -31.67% | O: 1.01% H: 0.43% C: 0.29%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 20.51% | O: 0.28% H: 0.38% C: 0.31%
ORTX | $16.7 0.0% 370K |

Health Technology

| 235.96% | O: 1.01% H: 7.6% C: 7.6%
GBIO | News | $2.995 -8.13% -8.85% 110K |

Health Technology

| -18.97% | O: 3.79% H: 2.61% C: -1.57%
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| -21.88% | O: 1.4% H: 1.39% C: 0.07%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 17.08% | O: 0.12% H: 0.0% C: -1.23%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| -2.7% | O: 0.9% H: 4.46% C: 2.68%
ABEO | News | $3.165 -7.19% -7.74% 2.2M |

Health Technology

| 26.29% | O: 2.79% H: 8.53% C: 0.78%
global therapy market

---

Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027; The increase in special drug designations to drive growth- Technavio
Published: 2023-03-16 (Crawled : 02:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 42.66% | O: 1.16% H: 0.73% C: 0.73%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -31.23% | O: 0.44% H: 0.29% C: 0.29%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 19.79% | O: 0.18% H: 0.77% C: 0.64%
ORTX | $16.7 0.0% 370K |

Health Technology

| 219.81% | O: -4.62% H: 4.44% C: -6.05%
GBIO | News | $2.995 -8.13% -8.85% 110K |

Health Technology

| -17.17% | O: -0.55% H: 6.69% C: 1.95%
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| -23.01% | O: -1.11% H: 2.97% C: 2.23%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 16.22% | O: -0.49% H: 0.39% C: 0.36%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| -4.42% | O: -2.65% H: 14.55% C: 9.09%
ABEO | News | $3.165 -7.19% -7.74% 2.2M |

Health Technology

| 20.99% | O: -2.29% H: 3.52% C: -0.78%
drug therapy market

---

Gene Therapy Market size is set to grow by USD 4,613.9 million from 2022 to 2027; Increase in special drug designations boosts the market growth - Technavio
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -41.62% | O: -0.68% H: 3.23% C: 1.55%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -2.56% | O: -0.16% H: 0.11% C: -0.76%
ORTX | $16.7 0.0% 370K |

Health Technology

| 241.48% | O: 0.62% H: 4.57% C: 2.04%
GBIO | News | $2.995 -8.13% -8.85% 110K |

Health Technology

| -38.22% | O: 0.0% H: 11.57% C: 6.4%
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| -34.61% | O: 3.52% H: 0.0% C: -1.99%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 24.8% | O: 0.22% H: 0.0% C: -0.86%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| 9.38% | O: -0.75% H: 7.14% C: 6.12%
ABEO | News | $3.165 -7.19% -7.74% 2.2M |

Health Technology

| -25.41% | O: 0.0% H: 4.4% C: 3.29%
drug set therapy growth market

---

Gene Therapy Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 39% of market growth- Technavio
Published: 2023-11-03 (Crawled : 23:00) - prnewswire.com
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| Email alert Add to watchlist
ALPMF | News | $9.5 43.47% 1.2K |

Health Technology

| Email alert Add to watchlist
ORTX | $16.7 0.0% 370K |

Health Technology

| Email alert Add to watchlist
ABEO | News | $3.165 -7.19% -7.74% 2.2M |

Health Technology

| Email alert Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| Email alert Add to watchlist
GBIO | News | $2.995 -8.13% -8.85% 110K |

Health Technology

| Email alert Add to watchlist
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| Email alert Add to watchlist
AAPL | $168.99 1.25% 1.24% 48M |

Electronic Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| Email alert Add to watchlist
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| Email alert Add to watchlist
america therapy market

---

Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan diseases is the major market trend- Technavio
Published: 2023-12-01 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K |

Health Technology

| -19.29% | O: 3.87% H: 0.0% C: 0.0%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -0.54% | O: 1.48% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -22.12% | O: -3.37% H: 4.51% C: 4.51%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 0.46% | O: -0.25% H: 0.68% C: 0.48%
ORTX | $16.7 0.0% 370K |

Health Technology

| 2.53% | O: -0.09% H: 0.0% C: 0.0%
GBIO | News | $2.995 -8.13% -8.85% 110K |

Health Technology

| 164.6% | O: 0.0% H: 38.05% C: 23.01%
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| -13.71% | O: -0.06% H: 0.35% C: 0.29%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 1.25% | O: 0.12% H: 0.97% C: 0.92%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| 116.0% | O: -5.76% H: 16.36% C: 15.07%
ABEO | News | $3.165 -7.19% -7.74% 2.2M |

Health Technology

| -35.83% | O: -2.43% H: 0.0% C: 0.0%
research growing therapy market

---

Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth - Technavio
Published: 2023-12-12 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K |

Health Technology

| -20.5% | O: -0.42% H: 0.0% C: 0.0%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 0.0% | O: 1.56% H: 0.51% C: 0.51%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -20.29% | O: -5.13% H: 5.41% C: 3.46%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.1% | O: 0.45% H: 0.75% C: 0.46%
ORTX | $16.7 0.0% 370K |

Health Technology

| 2.15% | O: 0.18% H: 0.43% C: 0.25%
GBIO | News | $2.995 -8.13% -8.85% 110K |

Health Technology

| 67.98% | O: 5.62% H: 3.72% C: -4.26%
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| -17.93% | O: 0.59% H: 1.35% C: 0.6%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 0.32% | O: 1.83% H: 0.04% C: -1.13%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| 114.93% | O: -0.46% H: 5.56% C: -1.12%
ABEO | News | $3.165 -7.19% -7.74% 2.2M |

Health Technology

| -31.24% | O: 0.65% H: 2.59% C: 0.86%
america therapy growth market

---

Global Glioblastoma Multiforme (GBM) Treatment Market Report 2023: Increasing Prevalence of Brain Disorders is Expected to Propel Growth
Published: 2023-05-17 (Crawled : 01:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| -10.48% | O: -1.32% H: 0.92% C: -1.34%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -4.34% | O: -0.51% H: 0.0% C: -1.05%
FUSN | $21.4 -0.09% -0.09% 270K |

Health Technology

| 369.3% | O: -1.54% H: 1.34% C: -2.67%
DFFN 4 | $6.6 11.68% -34.32% 350K |

Health Technology

| 14.59% | O: -0.25% H: 0.0% C: -0.78%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| -5.42% | O: 0.07% H: 0.03% C: -0.84%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 19.8% | O: -0.82% H: 0.03% C: -0.44%
propel report expected treatment global growth glioblastoma market

---

Sarcoma Therapeutics Market 2022-2026 | Patient Assistance Programs to Boost Growth | Technavio
Published: 2022-02-28 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -3.64% | O: -3.4% H: 7.54% C: 7.54%
CYTR | $0.092 |

Manufacturing

| -80.83% | O: 0.0% H: 0.0% C: -3.12%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 13.6% | O: 0.5% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -2.81% | O: -0.21% H: 0.0% C: 0.0%
KPTI | $1.1 0.92% 0.91% 1.2M |

Health Technology

| -89.61% | O: 0.1% H: 0.1% C: -1.62%
AGEN A | $7.42 14.86% 12.94% 1.3M |

Health Technology

| 177.9% | O: -1.31% H: 0.0% C: 0.0%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| -59.85% | O: -1.86% H: 4.92% C: -1.52%
program therapeutics growth

---

Insights on the Kidney Cancer Diagnostics and Therapeutics Global Market to 2026 - Key Motivators, Restraints and Opportunities
Published: 2021-08-05 (Crawled : 16:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M |

Health Technology

| -41.87% | O: -0.42% H: 0.31% C: 0.13%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 7.38% | O: 0.48% H: 0.24% C: 0.24%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 0.89% | O: 0.69% H: 0.37% C: 0.34%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -4.88% | O: 1.14% H: 0.3% C: 0.22%
EXEL | $23.7 1.76% 1.73% 1.5M |

Health Technology

| 41.22% | O: 0.0% H: 2.03% C: 1.25%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 24.24% | O: 1.48% H: 0.46% C: 0.43%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| -68.6% | O: 0.58% H: 4.05% C: 2.02%
cancer diagnostics kidney diagnostic

---

Cancer Gene Therapy Market To Reach a Valuation of USD 4047.8 Million by 2028 - Comprehensive Research Report by BrandEssence Market Research
Published: 2022-12-02 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 11.83% | O: 1.41% H: 0.0% C: -3.13%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| -2.1% | O: -0.61% H: 0.08% C: -0.29%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 9.5% | O: -1.08% H: 1.44% C: 1.28%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 16.64% | O: -0.29% H: 1.55% C: 1.2%
CRNX G | $43.32 -2.04% -2.08% 420K |

Health Technology

| 146.56% | O: -0.57% H: 5.9% C: 5.44%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 4.18% | O: -0.23% H: 0.79% C: 0.43%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| -46.53% | O: -0.99% H: 6.5% C: 3.0%
research report therapy cancer market

---

Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 27.65% | O: -0.06% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 12.32% | O: 6.22% H: 3.13% C: -0.56%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 18.54% | O: 2.81% H: 0.43% C: -0.2%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -14.94% | O: 0.18% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 26.03% | O: 2.59% H: 0.72% C: 0.63%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -38.76% | O: 1.22% H: 0.01% C: -1.7%
IOVA 4 | $11.69 -1.43% -1.45% 2.7M |

Health Technology

| 49.36% | O: 6.12% H: 4.99% C: 4.21%
INO | $10.1 -2.6% -2.67% 250K |

Health Technology

| 366.06% | O: 5.5% H: 4.35% C: 3.48%
GILD | $67.07 0.06% 0.06% 8.3M |

Health Technology

| -18.51% | O: 1.43% H: 0.36% C: -1.08%
ATRA | $0.7101 -1.18% -1.2% 700K |

Health Technology

| -81.7% | O: 2.58% H: 23.12% C: 20.85%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 16.63% | O: 7.08% H: 0.84% C: -0.43%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| -48.57% | O: 0.0% H: 7.14% C: 5.71%
covid-19 research global immunotherapy report impact technology market

---

Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published: 2022-06-27 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -24.74% | O: 0.47% H: 3.73% C: 3.73%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 4.75% | O: -1.55% H: 4.43% C: 0.03%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 17.74% | O: 1.86% H: 1.05% C: 0.24%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -25.18% | O: -0.16% H: 0.61% C: 0.18%
CRNX G | $43.32 -2.04% -2.08% 420K |

Health Technology

| 120.91% | O: 0.66% H: 1.22% C: -5.83%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 7.07% | O: -0.36% H: 1.22% C: 0.38%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 11.26% | O: -0.08% H: 0.45% C: -0.13%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| -33.33% | O: 1.85% H: 6.67% C: 3.03%
treatment therapy cancer market

---

Global Pancreatic Cancer Competitive Landscape Report 2023: Comprehensive Insights about 250+ Companies and 300+ Drugs
Published: 2023-05-08 (Crawled : 15:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -6.08% | O: -0.11% H: 0.72% C: 0.3%
TCRR 4 | $1.48 3.38% 3.9M |

Health Technology

| -21.28% | O: 6.91% H: 1.49% C: -2.49%
INCY | $51.72 0.14% 0.14% 1.5M |

Health Technology

| -22.27% | O: 0.03% H: 0.17% C: -1.19%
BNTX | News | $88.18 -0.35% -0.35% 280K |

Health Technology

| -18.76% | O: 4.23% H: 0.0% C: -4.4%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| -22.86% | O: 1.43% H: 2.11% C: -1.41%
companies report cancer pancreatic global

---

Worldwide Gene Therapy Industry to 2027 - Players Include Amgen, Biogen and Novartis Among Others
Published: 2022-03-04 (Crawled : 21:00) - prnewswire.com
QURE | $4.57 -3.79% -3.94% 640K |

Health Technology

| Email alert Add to watchlist
ABEO | News | $3.165 -7.19% -7.74% 2.2M |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| Email alert Add to watchlist
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| Email alert Add to watchlist
ORTX | $16.7 0.0% 370K |

Health Technology

| Email alert Add to watchlist
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| Email alert Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| Email alert Add to watchlist
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| Email alert Add to watchlist
ALPMF | News | $9.5 43.47% 1.2K |

Health Technology

| Email alert Add to watchlist
novartis gene therapy therapy

---

Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
Published: 2022-01-26 (Crawled : 13:30) - biospace.com/
TSVT | $4.28 -7.56% -8.18% 470K |

| -78.36% | O: 1.06% H: 2.71% C: -10.48%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 16.34% | O: 0.66% H: 0.26% C: -1.01%
BLUE | $0.9274 -4.45% -4.66% 8.1M |

Health Technology

| -88.14% | O: 1.29% H: 5.03% C: -1.78%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| -62.24% | O: 1.75% H: 3.78% C: -3.09%
commercialization

---

Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
Published: 2024-02-27 (Crawled : 15:30) - biospace.com/
TSVT | $4.28 -7.56% -8.18% 470K |

| -22.36% | O: 0.0% H: 8.64% C: 8.36%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -4.75% | O: -0.15% H: 0.31% C: 0.06%
BLBD | $35.03 -3.47% -3.6% 360K |

Producer Manufacturing

| 8.4% | O: 1.02% H: 1.29% C: 1.17%
ALVR | $0.7826 -1.05% -1.06% 150K |

Health Technology

| 8.3% | O: -1.42% H: 7.9% C: 3.52%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| -34.15% | O: 3.05% H: 5.92% C: 1.18%
pdufa commercial

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---